Delivery Order HHSD200201253663I-75D30121F00020
Award Date 12/3/20
Potential Completion Date 9/29/24
Potential Value $1.9M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27708, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Duke University's Office of Research Administration received a delivery order contract valued at $1.07M under the Clinical Immunization Safety Assessment (CISA) master IDIQ vehicle from the CDC Pittsburgh on September 29, 2017. This cost-no-fee contract, which extended through September 28, 2022, supported COVID response efforts and was performed at Duke's Durham, North Carolina location. The award was made on a competitive basis with no set-aside designation. The Clinical Immunization Safety...
- This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Duke University's Office of Research Administration Division. The $263,144.00 award is a delivery order under the CDC's Clinical Immunization Safety Assessment (CISA) master indefinite-delivery, indefinite-quantity (IDIQ) contract, which has a potential value of $86 million through September 2028. Under this contract, Duke University provides clinical research...
- The Centers for Disease Control and Prevention (CDC) awarded Duke University a $2,180,450.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract for the 2023 Clinical Immunization Safety Assessment (CISA) base contract. This cost-no-fee delivery order contract will provide clinical research and immunization safety assessment services to the CDC through September 27, 2026. The contract was awarded on an unrestricted basis, without any set-aside designations. As a prime contractor, Duke...
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $608,717 delivery order contract to Duke University's Office of Research Administration Division to provide Clinical Immunization Safety Assessment (CISA) services. The contract has a period of performance ending on September 30, 2020 and is not associated with a set-aside. This delivery order is part of a larger CISA indefinite delivery, indefinite quantity (IDIQ) contract with a...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University, a private university and non-profit organization, to provide clinical research and immunization safety assessment services. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $465,451.00 and was awarded on September 29, 2015, with a completion date...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University. The contract was awarded under the Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) vehicle. The contract has a ceiling value of $713,975.00 and was awarded on September 29, 2016, with an ultimate completion date of October 28, 2019. The contract is for the delivery of clinical research and immunization safety assessment services. The...
- This is a federal contract award to Duke University by the Centers for Disease Control and Prevention (CDC) under the Clinical Immunization Safety Assessment (CISA) indefinite delivery indefinite quantity (IDIQ) vehicle. The $1,738,484.00 delivery order is for the CISA COVID MATERNAL STUDY, which will be performed in Durham, NC. The contract does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor for this award. The contract...
- Duke University's Office of Research Administration was awarded a delivery order under the 2023 Clinical Immunization Safety Assessment (CISA) Base IDIQ contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh on September 28, 2023. This cost-plus-no-fee contract, valued at $874,846, supports immunization safety assessment services and will be performed in Durham, North Carolina, with an ultimate completion date of September 27, 2028. The award was made through a competitive...
- Duke University Office of Research Administration Division was awarded a $499,784 firm fixed price delivery order against its Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract with the Centers for Disease Control and Prevention (CDC). The delivery order is for a CISA SHINGRIX lead study to be performed in Durham, North Carolina by November 2022. Duke University holds the CISA IDIQ contract with CDC, valued at up to $86 million through...
- This federal contract was awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Duke University to provide Clinical Immunization Safety Assessment (CISA) services. The contract is a Delivery Order under the CISA master IDIQ contract, which has a potential value of $86 million through September 2028. Two task orders have been awarded to date - one valued at $875,045 for CISA services in Durham, NC from September 2023 to...